Want to join the conversation?
Pharmaceutical giant $PFE said that it will acquire $ANAC, a biopharmaceutical company for $99.25 per $ANAC share, in cash, for a total transaction value, net of cash, of approx. $5.2Bil. $ANAC's flagship asset, crisaborole, a non-steroidal topical PDE4 inhibitor with anti-inflammatory properties, is currently under review by the FDA for eczema.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.